BRIEF-Bharat Biotech Says 13,000 Volunteers Have Been Administered 2nd Dose In Phase-3 Clinical Trials Of COVAXIN

BHARAT BIOTECH JOINT MANAGING DIRECTOR SAYS 13,000 VOLUNTEERS HAVE BEEN SUCCESSFULLY ADMINISTERED 2ND DOSE IN PHASE-3 CLINICAL TRIALS OF COVAXIN-TWEET Source text : https://bit.ly/3c2w57a